KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Shares Issued (2016 - 2025)

Idexx Laboratories has reported Shares Issued over the past 17 years, most recently at $17.9 million for Q4 2025.

  • Quarterly results put Shares Issued at $17.9 million for Q4 2025, up 34.81% from a year ago — trailing twelve months through Dec 2025 was $93.4 million (up 109.84% YoY), and the annual figure for FY2025 was $93.4 million, up 109.84%.
  • Shares Issued for Q4 2025 was $17.9 million at Idexx Laboratories, down from $51.0 million in the prior quarter.
  • Over the last five years, Shares Issued for IDXX hit a ceiling of $51.0 million in Q3 2025 and a floor of $4.9 million in Q3 2022.
  • Median Shares Issued over the past 5 years was $11.5 million (2022), compared with a mean of $13.4 million.
  • Peak annual rise in Shares Issued hit 920.22% in 2025, while the deepest fall reached 65.55% in 2025.
  • Idexx Laboratories' Shares Issued stood at $9.1 million in 2021, then soared by 36.7% to $12.5 million in 2022, then decreased by 9.29% to $11.3 million in 2023, then rose by 16.99% to $13.3 million in 2024, then soared by 34.81% to $17.9 million in 2025.
  • The last three reported values for Shares Issued were $17.9 million (Q4 2025), $51.0 million (Q3 2025), and $17.3 million (Q2 2025) per Business Quant data.